A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2020-09-18
Target enrollment:
Participant gender:
Summary
A study to assess safety, tolerability and clinical effects of single and repeat dose
intra-articular administration of UBX0101 in patients with moderate to severe painful knee
osteoarthritis (OA).